Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Early and accurate diagnosis of Alzheimer's disease (AD) and its prodromal period mild cognitive impairment (MCI) is essential for the delayed disease progression and the improved quality of patients' life. The emerging computer-aided diagnostic methods that combine deep learning with structural magnetic resonance imaging (sMRI) have achieved encouraging results, but some of them are limit of issu...
Accumulation of beta-amyloid in the brain and cognitive decline are considered hallmarks of Alzheimer's disease. Knowing from previous studies that these two factors can manifest in the retina, the aim was to investigate whether a deep learning method was able to predict the cognition of an individual from a RGB image of his retina and metadata. A deep learning model, EfficientNet, was used to pre...
Research on segmentation of the hippocampus in magnetic resonance images through deep learning convolutional neural networks (CNNs) shows promising re...
BACKGROUND: The three core pathologies of Alzheimer's disease (AD) are amyloid pathology, tau pathology, and neurodegeneration. Biomarkers exist for e...
The study aimed to explore the risk factors of effects of patients with vascular mild cognitive impairment (VaMCI) through functional magnetic resonan...
The long-term use of transfer support robots in nursing facilities is an important option for improving the efficiency of care work. The "Resyone" tra...
Polymorphism in the structure of amyloid fibrils suggests the existence of many different assembly pathways. Characterization of this heterogeneity is...
Measuring evolutionary rates at the residue level is indispensable for gaining structural and functional insights into proteins. State-of-the-art tool...
BACKGROUND: Alzheimer's disease (AD) is the most frequent cause of dementia among the elderly. The accumulation of amyloid beta (Aβ) and its downstrea...
This study was to explore the application of MRI based on artificial intelligence technology combined with neuropsychological assessment to the cognit...
Alzheimer's disease (AD) is a neurodegenerative disease involving the decline of cognitive ability with illness progresses. At present, the diagnosis ...
Impairment of navigation is one of the earliest symptoms of Alzheimer's disease (AD), but to date studies have involved proxy tests of navigation rath...
Fully automated and volumetric segmentation of critical tumors may play a crucial role in diagnosis and surgical planning. One of the most challenging...
Specific brain structures (gray matter regions and white matter tracts) play a dominant role in determining cognitive decline and explain the heteroge...
For now, Alzheimer's disease (AD) is incurable. But if it can be diagnosed early, the correct treatment can be used to delay the disease. Most of the ...
Remote health monitoring can help prevent disease at the earlier stages. The Internet of Things (IoT) concepts have recently advanced, enabling omnipr...
Alzheimer's Disease (AD) is a progressive, neurodegenerative brain disease and is an incurable ailment. No drug exists for AD, but its progression can...
Identifying the molecular systems and proteins that modify the progression of Alzheimer's disease and related dementias (ADRD) is central to drug targ...
The majority of clinical trials fail due to low efficacy of investigated drugs, often resulting from a poor choice of target protein. Existing computa...
Genetic algorithms have a proven capability to explore a large space of solutions, and deal with very large numbers of input features. We hypothesized...